| 000 | 01628 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513103646.0 | ||
| 264 | 0 | _c19970317 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBishop, M R | |
| 245 | 0 | 0 |
_aLong-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cOct 1996 |
||
| 300 |
_a747-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlast Crisis _xmortality |
| 650 | 0 | 4 | _aBone Marrow Purging |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
| 650 | 0 | 4 | _aHLA Antigens |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _ximmunology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Accelerated Phase _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aHenslee-Downey, P J | |
| 700 | 1 | _aAnderson, J R | |
| 700 | 1 | _aRomond, E H | |
| 700 | 1 | _aMarciniak, E | |
| 700 | 1 | _aYankey, R | |
| 700 | 1 | _aReeves, M | |
| 700 | 1 | _aThompson, J S | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 18 _gno. 4 _gp. 747-53 |
|
| 999 |
_c8891757 _d8891757 |
||